URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Anton Porsteinsson

Concepts (212)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Alzheimer Disease
31
1997
299
4.920
Why?
Dementia
8
1997
104
2.710
Why?
Valproic Acid
9
1997
54
2.160
Why?
Psychomotor Agitation
9
1997
43
1.720
Why?
Mental Disorders
7
1996
351
1.440
Why?
Amyloid beta-Peptides
4
2011
57
1.260
Why?
Memantine
2
2007
14
1.240
Why?
Excitatory Amino Acid Antagonists
2
2007
40
1.210
Why?
Receptors, N-Methyl-D-Aspartate
3
2003
87
1.210
Why?
Aged
38
1996
7392
1.070
Why?
Cholinesterase Inhibitors
5
2000
20
1.070
Why?
Serotonin Uptake Inhibitors
6
2002
35
1.040
Why?
Cognition Disorders
8
2008
291
1.000
Why?
Aging
2
2009
705
0.970
Why?
Peptide Fragments
3
2011
307
0.940
Why?
Sertraline
5
2006
9
0.930
Why?
Neuropsychological Tests
8
2000
391
0.890
Why?
Depressive Disorder, Major
3
1997
173
0.800
Why?
Aged, 80 and over
20
1996
2588
0.720
Why?
Psychotropic Drugs
4
1997
38
0.710
Why?
Double-Blind Method
14
2000
996
0.700
Why?
Depression
7
2001
442
0.560
Why?
Humans
43
1996
37165
0.530
Why?
Female
31
1996
20222
0.520
Why?
Male
30
1996
20139
0.490
Why?
Neuroprotective Agents
5
2002
125
0.470
Why?
Depressive Disorder
4
2006
326
0.440
Why?
Antimanic Agents
2
2001
8
0.420
Why?
Enzyme Inhibitors
2
2003
441
0.420
Why?
Antibodies, Monoclonal, Humanized
2
2012
94
0.410
Why?
Severity of Illness Index
5
2000
943
0.400
Why?
Psychotic Disorders
3
2003
68
0.380
Why?
Treatment Outcome
12
2000
2671
0.360
Why?
Activities of Daily Living
4
2000
273
0.360
Why?
Antidepressive Agents
2
2010
93
0.360
Why?
Drug Therapy, Combination
3
1997
397
0.350
Why?
Anticonvulsants
4
2001
125
0.340
Why?
Mental Status Schedule
5
2005
33
0.340
Why?
Cognition
3
2000
232
0.320
Why?
Middle Aged
14
1996
10013
0.320
Why?
Dose-Response Relationship, Drug
6
2000
1142
0.310
Why?
Antipsychotic Agents
4
2003
116
0.310
Why?
GABA Agents
1
1997
1
0.300
Why?
Street Drugs
1
1997
19
0.290
Why?
Alcoholism
1
1997
101
0.270
Why?
Psychiatric Status Rating Scales
6
2005
332
0.250
Why?
Substance-Related Disorders
1
1997
212
0.240
Why?
Principal Component Analysis
2
2010
32
0.240
Why?
Disease Progression
3
2008
533
0.220
Why?
Citalopram
1
2012
1
0.210
Why?
Behavioral Symptoms
2
2000
15
0.210
Why?
Neuroimaging
1
2012
11
0.210
Why?
Phosphoric Diester Hydrolases
1
2012
54
0.210
Why?
Inositol
1
2011
26
0.210
Why?
Genetic Variation
1
2012
147
0.200
Why?
Platelet Aggregation Inhibitors
1
2011
60
0.200
Why?
Discriminant Analysis
1
2010
24
0.190
Why?
Suicide
1
1997
418
0.190
Why?
Galantamine
1
2000
1
0.190
Why?
Propylamines
1
2009
7
0.180
Why?
Adrenergic Uptake Inhibitors
1
2009
22
0.180
Why?
Brain
3
2011
1228
0.180
Why?
Spiro Compounds
1
2008
5
0.170
Why?
Prospective Studies
3
2005
1696
0.170
Why?
Diabetes Complications
1
2009
66
0.170
Why?
Brief Psychiatric Rating Scale
2
2003
13
0.170
Why?
Naproxen
1
2008
4
0.170
Why?
Quinolones
1
2008
27
0.160
Why?
Risk Factors
6
1997
2331
0.160
Why?
Follow-Up Studies
5
2006
1889
0.160
Why?
Indoles
1
2008
104
0.160
Why?
Pyrazoles
1
2008
59
0.160
Why?
Piperazines
1
2008
76
0.150
Why?
Sulfonamides
1
2008
103
0.150
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
93
0.150
Why?
Antidepressive Agents, Second-Generation
1
2006
13
0.150
Why?
Clinical Trials as Topic
3
2001
685
0.140
Why?
Caregivers
2
2003
82
0.140
Why?
Azepines
1
2006
11
0.140
Why?
Alanine
1
2006
93
0.140
Why?
Endopeptidases
1
2006
59
0.140
Why?
Placebos
4
2001
185
0.130
Why?
Psychoanalytic Interpretation
1
2005
5
0.130
Why?
Obesity
1
2009
349
0.130
Why?
Proportional Hazards Models
3
2009
426
0.120
Why?
Social Control, Formal
1
2003
10
0.120
Why?
Long-Term Care
1
2003
65
0.110
Why?
Benzodiazepines
1
2002
26
0.110
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
50
0.110
Why?
Magnetic Resonance Imaging
3
2011
1019
0.100
Why?
Apolipoprotein E4
2
2009
9
0.100
Why?
Genotype
2
2011
473
0.090
Why?
Time Factors
4
2001
3234
0.090
Why?
Statistics, Nonparametric
1
2001
269
0.090
Why?
Calcium
1
2007
1135
0.090
Why?
Educational Status
2
2010
182
0.090
Why?
Regression Analysis
1
2001
539
0.090
Why?
Outcome Assessment (Health Care)
2
2011
301
0.080
Why?
Epilepsy
1
2001
166
0.080
Why?
Patient Dropouts
2
2006
29
0.080
Why?
Analysis of Variance
1
2001
749
0.080
Why?
Questionnaires
1
2003
1061
0.080
Why?
Neurotransmitter Agents
1
1997
48
0.080
Why?
Thyroid Function Tests
1
1996
15
0.070
Why?
Longitudinal Studies
2
2008
413
0.070
Why?
Thyrotropin
1
1996
32
0.070
Why?
Reproducibility of Results
2
2010
903
0.070
Why?
Cause of Death
1
1997
158
0.070
Why?
Patient Care Team
1
1997
199
0.060
Why?
Comorbidity
1
1997
377
0.060
Why?
Geriatric Assessment
2
2001
168
0.060
Why?
Randomized Controlled Trials as Topic
2
2001
415
0.060
Why?
Nursing Homes
2
2005
192
0.060
Why?
Retrospective Studies
2
2009
2302
0.060
Why?
Mood Disorders
2
2002
61
0.060
Why?
Social Support
2
2003
233
0.060
Why?
Signal Transduction
1
2002
1629
0.060
Why?
Age Factors
2
2001
1152
0.050
Why?
New York
1
1997
1378
0.050
Why?
Genome-Wide Association Study
1
2012
23
0.050
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
71
0.050
Why?
Cognitive Therapy
1
2012
41
0.050
Why?
Pyridines
1
2012
85
0.050
Why?
Adult
3
1996
11572
0.050
Why?
Atrophy
1
2011
67
0.050
Why?
Genomics
1
2012
49
0.050
Why?
Electroencephalography
1
2012
180
0.050
Why?
Polymorphism, Single Nucleotide
1
2012
90
0.050
Why?
Models, Genetic
1
2012
162
0.050
Why?
Multicenter Studies as Topic
1
2011
127
0.050
Why?
Diagnostic Imaging
1
2012
86
0.050
Why?
Stroop Test
1
2010
2
0.050
Why?
Word Association Tests
1
2010
4
0.050
Why?
Trail Making Test
1
2010
7
0.050
Why?
Apathy
1
2010
1
0.050
Why?
Delusions
1
2010
7
0.050
Why?
Administration, Oral
1
2011
314
0.050
Why?
Verbal Behavior
1
2010
27
0.050
Why?
Hallucinations
1
2010
14
0.050
Why?
Brain Mapping
1
2012
205
0.050
Why?
Reading
1
2010
22
0.050
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2010
40
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
472
0.050
Why?
Adolescent
3
1996
5044
0.050
Why?
Polymorphism, Genetic
1
2011
200
0.050
Why?
Cross-Cultural Comparison
1
2010
35
0.050
Why?
Visual Cortex
1
2012
125
0.050
Why?
Observer Variation
1
2010
146
0.050
Why?
Medication Adherence
1
2010
22
0.050
Why?
Statistics as Topic
1
2010
189
0.040
Why?
Memory
1
2010
104
0.040
Why?
PubMed
1
2009
1
0.040
Why?
Space Perception
1
2010
84
0.040
Why?
Body Weight
1
2000
337
0.040
Why?
Overweight
1
2009
42
0.040
Why?
Psychometrics
1
2010
232
0.040
Why?
Patient Compliance
1
2010
177
0.040
Why?
Drug Toxicity
1
2008
17
0.040
Why?
Animals
2
2002
16416
0.040
Why?
Chi-Square Distribution
1
2010
347
0.040
Why?
Multivariate Analysis
1
2010
548
0.040
Why?
Cohort Studies
1
2012
984
0.040
Why?
Confidence Intervals
1
2008
164
0.040
Why?
Predictive Value of Tests
1
2010
609
0.040
Why?
Body Mass Index
1
2009
229
0.040
Why?
Insulin-Like Growth Factor I
1
2008
106
0.040
Why?
Saccharomyces cerevisiae
1
2012
370
0.040
Why?
United States
2
2003
2847
0.040
Why?
Sex Factors
1
2010
613
0.040
Why?
Communication
1
2010
282
0.040
Why?
Prognosis
1
2010
1078
0.040
Why?
Glucose
1
2009
401
0.040
Why?
Problem Solving
1
2006
45
0.040
Why?
Affect
1
2006
78
0.040
Why?
Amyloid Precursor Protein Secretases
1
2006
14
0.040
Why?
Aspartic Acid Endopeptidases
1
2006
21
0.030
Why?
Outpatients
1
2005
31
0.030
Why?
Counseling
1
2006
93
0.030
Why?
Cost of Illness
1
2006
79
0.030
Why?
Insulin
1
2009
670
0.030
Why?
Quality of Life
1
2010
528
0.030
Why?
Quality Assurance, Health Care
1
2006
130
0.030
Why?
Homes for the Aged
1
2005
58
0.030
Why?
Combined Modality Therapy
1
2006
491
0.030
Why?
Clinical Protocols
1
2005
107
0.030
Why?
Primary Health Care
1
2010
518
0.030
Why?
Drug Administration Schedule
1
2005
374
0.030
Why?
Research Design
1
2006
340
0.030
Why?
Pilot Projects
1
2005
446
0.030
Why?
Ginkgo biloba
1
2003
3
0.030
Why?
Homocysteine
1
2003
26
0.030
Why?
Drug Evaluation
1
2003
99
0.030
Why?
Phytotherapy
1
2003
18
0.030
Why?
Plant Extracts
1
2003
21
0.030
Why?
Professional-Family Relations
1
2003
61
0.030
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2003
46
0.030
Why?
Vitamin E
1
2003
87
0.030
Why?
Child, Preschool
2
1996
2737
0.030
Why?
Anti-Inflammatory Agents
1
2003
115
0.030
Why?
Diagnosis, Differential
1
2005
889
0.030
Why?
Decision Making
1
2003
227
0.020
Why?
Sleep Disorders
1
2001
70
0.020
Why?
Research
1
2001
185
0.020
Why?
Child
2
1996
4342
0.020
Why?
Patient Selection
1
2001
223
0.020
Why?
Thyroxine
1
1996
45
0.020
Why?
Thyroid Diseases
1
1996
20
0.020
Why?
Triiodothyronine
1
1996
49
0.020
Why?
Cost-Benefit Analysis
1
1996
215
0.020
Why?
Infant
1
2001
2320
0.020
Why?
Hospitalization
1
1996
385
0.010
Why?
Mass Screening
1
1996
270
0.010
Why?

Visualizations


Porsteinsson's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department